OneOme offers its RightMed® Test in all U.S. states and its RightMed® Comprehensive Test in select international locations. Please Contact us for more information on availability within your area.
OneOme has the following clinical laboratory certifications:
Clinical Laboratory Improvement Amendments (CLIA) Certificate of Accreditation
Expiration Date: 10/25/2022
College of American Pathologists (CAP) Accreditation
Expiration Date: 10/03/2022
State of Rhode Island License
Expiration Date: 12/30/2022
State of Maryland License
Expiration Date: Non-expiring
State of Pennsylvania
Expiration Date: 08/15/2021
State of California
Expiration Date: 2/25/2021
State of New York
Number: PFI: 9226
Expiration Date: 6/30/2021
OneOme NPI number: 1669836227
OneOme Tax Identification Number: 46-4356584
Indications for use
The RightMed Test is prescription use only. The RightMed Test is a qualitative genotyping assessment system applied to genomic DNA isolated from human saliva collected using the OraCollect Dx OCD-100 to simultaneously detect, report, and interpret genetic variants in a broad multigene test. The interpretation of genomic data is intended to inform healthcare providers of pharmacogenomic associations which are categorized by Level of Concern and Level of Evidence. The RightMed Test describes the detected genotypes associated with metabolism, transport, or other physiological mechanisms by which some therapeutics interact with the body, but does not predict whether a person will or will not respond to, or experience adverse events with, a particular therapeutic.
The RightMed Test reports are indicated for reporting certain variants in the following genes: CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP4F2, CYP3A4, CYP3A5, F2, F5, TPMT, DPYD, NUDT15, VKORC1, SLCO1B1, COMT, DRD2, COMT, HTR2A, HTR2C, IFNL4, UGT1A1, GRIK4, HLA-A, HLA-B, OPRM1, SLC6A4, CYP2C Cluster
RightMed Test results are not a substitute for medical advice and should only be used in consultation with a medical professional. The RightMed Test does not determine the best medication for the patient; it is intended to inform healthcare providers of pharmacogenetic information and professional guidelines associated with the detected genotypes and predicted phenotypes. Information included is based upon scientific literature and does not take into account other genetic variants and environmental or social factors that may impact each patient. Other factors include, but are not limited to, environmental factors (e.g., smoking), health factors (e.g., diet), social and familial factors, various medical conditions, and drug-to-drug interactions. Administration of any medication requires careful therapeutic monitoring regardless of the phenotype or genotype-derived interaction reported. As a matter of practice, OneOme will routinely update its pharmacogenomic database as new information becomes available to the scientific community. Clinical annotations, including phenotype summaries, are therefore dependent on the date of generation and/or the database version used to generate that report.